Works matching DE "VASCULAR endothelial growth factor receptors"


Results: 1865
    1
    2
    3
    4
    5
    6

    Regorafenib versus local standard of care in patients with grade 2–3 meningioma no longer eligible for loco-regional treatments: a phase II randomized controlled trial (the MIRAGE study).

    Published in:
    Trials, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s13063-025-08997-2
    By:
    • Bosio, Alberto;
    • Cerretti, Giulia;
    • Padovan, Marta;
    • Del Bianco, Paola;
    • Polano, Maurizio;
    • Mandruzzato, Susanna;
    • Indraccolo, Stefano;
    • Manara, Renzo;
    • Librizzi, Giovanni;
    • Caccese, Mario;
    • Corrà, Martina;
    • Maccari, Marta;
    • Lonardi, Sara;
    • De Salvo, Gian Luca;
    • Lombardi, Giuseppe
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14

    Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma.

    Published in:
    Journal of Neuro-Oncology, 2017, v. 131, n. 3, p. 603, doi. 10.1007/s11060-016-2332-5
    By:
    • Kalpathy-Cramer, Jayashree;
    • Chandra, Vyshak;
    • Da, Xiao;
    • Ou, Yangming;
    • Emblem, Kyrre;
    • Muzikansky, Alona;
    • Cai, Xuezhu;
    • Douw, Linda;
    • Evans, John;
    • Dietrich, Jorg;
    • Chi, Andrew;
    • Wen, Patrick;
    • Stufflebeam, Stephen;
    • Rosen, Bruce;
    • Duda, Dan;
    • Jain, Rakesh;
    • Batchelor, Tracy;
    • Gerstner, Elizabeth
    Publication type:
    Article
    15

    Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas.

    Published in:
    Journal of Neuro-Oncology, 2015, v. 121, n. 2, p. 297, doi. 10.1007/s11060-014-1631-y
    By:
    • Norden, Andrew;
    • Schiff, David;
    • Ahluwalia, Manmeet;
    • Lesser, Glenn;
    • Nayak, Lakshmi;
    • Lee, Eudocia;
    • Rinne, Mikael;
    • Muzikansky, Alona;
    • Dietrich, Jorg;
    • Purow, Benjamin;
    • Doherty, Lisa;
    • LaFrankie, Debra;
    • Pulverenti, Julee;
    • Rifenburg, Jennifer;
    • Ruland, Sandra;
    • Smith, Katrina;
    • Gaffey, Sarah;
    • McCluskey, Christine;
    • Ligon, Keith;
    • Reardon, David
    Publication type:
    Article
    16
    17

    Phase I and pharmacokinetic trial of PTC299 in pediatric patients with refractory or recurrent central nervous system tumors: a PBTC study.

    Published in:
    Journal of Neuro-Oncology, 2015, v. 121, n. 1, p. 217, doi. 10.1007/s11060-014-1665-1
    By:
    • Packer, Roger;
    • Rood, Brian;
    • Turner, David;
    • Stewart, Clinton;
    • Fisher, Michael;
    • Smith, Christopher;
    • Young-Pouissant, Tina;
    • Goldman, Stewart;
    • Lulla, Rishi;
    • Banerjee, Anu;
    • Pollack, Ian;
    • Kun, Larry;
    • Onar-Thomas, Arzu;
    • Wu, Shengjie;
    • Boyett, James;
    • Fouladi, Maryam
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Vascular endothelial growth factor receptor 2 (VEGFR2) correlates with long-term survival in patients with advanced high-grade serous ovarian cancer (HGSOC): a study from the Tumor Bank Ovarian Cancer (TOC) Consortium.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 4, p. 1063, doi. 10.1007/s00432-019-02877-4
    By:
    • Guan, Jun;
    • Darb-Esfahani, Silvia;
    • Richter, Rolf;
    • Taube, Eliane T.;
    • Ruscito, Ilary;
    • Mahner, Sven;
    • Woelber, Linn;
    • Prieske, Katharina;
    • Concin, Nicole;
    • Vergote, Ignace;
    • Van Nieuwenhuysen, Els;
    • Achimas-Cadariu, Patriciu;
    • Glajzer, Joanna;
    • Woopen, Hannah;
    • Stanske, Mandy;
    • Kulbe, Hagen;
    • Denkert, Carsten;
    • Sehouli, Jalid;
    • Braicu, Elena Ioana
    Publication type:
    Article
    31
    32

    Phase I trial of dovitinib (TKI258) in recurrent glioblastoma.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 7, p. 1581, doi. 10.1007/s00432-016-2161-0
    By:
    • Schäfer, Niklas;
    • Gielen, Gerrit;
    • Kebir, Sied;
    • Wieland, Anja;
    • Till, Andreas;
    • Mack, Frederic;
    • Schaub, Christina;
    • Tzaridis, Theophilos;
    • Reinartz, Roman;
    • Niessen, Michael;
    • Fimmers, Rolf;
    • Simon, Matthias;
    • Coch, Christoph;
    • Fuhrmann, Christine;
    • Herrlinger, Ulrich;
    • Scheffler, Björn;
    • Glas, Martin
    Publication type:
    Article
    33
    34
    35

    Betulin, a Newly Characterized Compound in Acacia auriculiformis Bark, Is a Multi-Target Protein Kinase Inhibitor.

    Published in:
    Molecules, 2021, v. 26, n. 15, p. 4599, doi. 10.3390/molecules26154599
    By:
    • Ahmadu, Augustine A.;
    • Delehouzé, Claire;
    • Haruna, Anas;
    • Mustapha, Lukman;
    • Lawal, Bilqis A.;
    • Udobre, Aniefiok;
    • Baratte, Blandine;
    • Triscornia, Camilla;
    • Autret, Axelle;
    • Robert, Thomas;
    • Bulinski, Jeannette Chloë;
    • Rousselot, Morgane;
    • Simoes Eugénio, Mélanie;
    • Dimanche-Boitrel, Marie-Thérèse;
    • Petzer, Jacobus P.;
    • Legoabe, Lesetja J.;
    • Bach, Stéphane
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43

    Antiangiogenic Effects of Coumarins against Cancer: From Chemistry to Medicine.

    Published in:
    Molecules, 2019, v. 24, n. 23, p. 4278, doi. 10.3390/molecules24234278
    By:
    • Majnooni, Mohammad Bagher;
    • Fakhri, Sajad;
    • Smeriglio, Antonella;
    • Trombetta, Domenico;
    • Croley, Courtney R.;
    • Bhattacharyya, Piyali;
    • Sobarzo-Sánchez, Eduardo;
    • Farzaei, Mohammad Hosein;
    • Bishayee, Anupam;
    • Nakagawa-Goto, Kyoko
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50